What Percentage of Thyroid Nodules Are Cancerous?

About 5 to 15 out of every 100 thyroid nodules that get checked turn out to be cancer.¹ That average is only a starting point. What your nodule looks like on ultrasound and under the microscope can move your own odds well below it or well above it. And when a nodule is cancer, it is usually a slow-growing type with an excellent outlook.

Why Thyroid Nodules Are So Common

How often nodules turn up depends on how hard anyone looks. A doctor can feel a nodule in only about 2 to 6 out of 100 adults.² Ultrasound finds them in about 19 to 35 out of 100.³ When the whole thyroid is examined after death, nodules show up in anywhere from 8 to 65 out of 100 people.⁴ They also become more common with age, and older people tend to have more than one.⁵

Most of these lumps are not a disease. A typical benign nodule is an area of overgrown normal thyroid tissue, a fluid-filled cyst, or a benign growth called an adenoma. They usually cause no symptoms and are found by touch or on imaging. A few grow large enough to press on the windpipe or interfere with swallowing, and that is a reason to treat one even when it is benign.

In a large real-world series, more than 7,000 nodules were checked at one big clinic, and about 13 in 100 were cancer.⁶ The overall percentage depends on which nodules were counted, though. It comes from nodules doctors chose to check, and those tend to be the more suspicious ones. Nodules found by accident and never biopsied are mostly tiny and harmless, so the true rate across all nodules is probably lower.

Most nodules leave the rest of the gland making hormone normally, so thyroid blood tests are usually normal. The first steps are usually a blood test of thyroid function and a dedicated thyroid ultrasound, which sort out most of the uncertainty before any needle is used.

What Your Ultrasound Score Says About Your Risk

Your ultrasound report may give a TI-RADS score, from TR1 to TR5, which estimates how suspicious the nodule looks. Radiologists build it from features. In solid, dark-looking nodules, tiny bright specks (microcalcifications), a shape taller than it is wide, and jagged edges are the strongest warning signs.⁷ In nodules that are partly fluid-filled or brighter on the scan, the same signs carry only a middle level of risk.⁸ Nodules that are mostly fluid are far less likely to be cancer: those that are over 75 percent fluid carry about one-fifth the odds of mostly solid ones.⁹

In numbers, nodules scored TR3, called mildly suspicious, were cancer in about 8 in 100 cases that were biopsied.¹⁰ The highly suspicious category, TR5, is the level that best separates cancer from benign nodules.¹¹ Of the main scoring systems, the American College of Radiology’s TI-RADS performed best.¹² It doesn’t catch everything, though. At that level the scoring misses roughly a quarter to a third of cancers.¹³ Because of the misses, some doctors also biopsy TR4 nodules so fewer cancers slip by, accepting more benign biopsies as the cost.¹⁴

Whether you need a biopsy combines the ultrasound score with the nodule’s size. Low scores usually mean no biopsy, just a repeat ultrasound later or nothing at all. Higher scores lower the size at which a biopsy is advised. It is fair to ask your doctor which size cutoff applied to your nodule and why.

“Hypoechoic” means darker than normal thyroid on the screen, a mild warning sign when the nodule is solid. “Spongiform” or “cystic” describes fluid-filled spaces and points toward benign. “Microcalcifications” are tiny bright dots and raise concern.

An ultrasound is a picture of shape, texture and edges. It estimates risk but cannot confirm cancer, which only cells examined under a microscope can do. Radiologists can also differ a little, because reading the features involves judgment, so a borderline score is not a sharp line.

The scan usually looks at the lymph nodes beside the thyroid as well as the nodule itself. Nodes that look enlarged or abnormal can raise concern and may be biopsied too, whatever the nodule’s score. Normal-looking nodes are reassuring, but they don’t by themselves rule out cancer in the nodule.

What Your Biopsy Result Means

A fine needle aspiration (FNA) draws cells from the nodule with a thin needle, usually guided by ultrasound. Your report will begin with one of six Bethesda categories, each tied to a cancer risk and a next step.¹⁵ Here is the risk in each, from one large hospital series:

Categories III and IV are often called indeterminate, meaning the cells can’t settle the question either way. Their rates vary between hospitals. In another series, category III was cancer in about 30 in 100 and category IV in about 47 in 100.²¹ So ask what rates your own lab sees, because they can differ widely. One reason for the drift: a borderline growth called NIFTP was reclassified as not cancer in 2016–2018, which lowered the cancer rates for these middle categories.²²

The procedure itself is usually done in a clinic in about 20 to 30 minutes, with local numbing or none. Several small needle passes are taken from the nodule. Mild soreness or a small bruise for a day or two is common, and results generally come back within a few days to a week.

A benign result is reassuring but not a full guarantee. A few percent of benign results later prove to be cancer because the needle can miss. That is why doctors usually repeat an ultrasound afterward to confirm the nodule is stable, and growth or new warning signs on later scans can prompt a second biopsy.

A nondiagnostic result says nothing about cancer, because the sample simply held too few cells to read. It is neither good nor bad news. Repeating the biopsy often gives a usable answer, and some clinics check the sample at the bedside to see whether enough cells were collected. Cystic nodules are more likely to be nondiagnostic because fluid contains few thyroid cells.

Other Things That Raise or Lower Your Odds

Bigger does not reliably mean more dangerous.²³ Nodules 3 to 6 cm had somewhat higher odds of cancer than those under 3 cm, after accounting for age and sex.²⁴ Nodules 6 cm or larger had slightly lower odds than those under 3 cm.²⁵ Size still matters for other reasons, such as pressing on the windpipe or deciding whether a biopsy is advised.

A thyroid with several nodules has a somewhat lower chance of cancer than one with a single nodule.²⁶ The difference is modest, so each nodule in a multinodular thyroid is still judged on its own ultrasound look.

The chance that a new nodule is cancer falls with age, from about 23 in 100 patients aged 20 to 30 to about 13 in 100 over 70.²⁷ But cancers found in older people are more often aggressive types.²⁸ Sex and childhood matter too. In one large group of people with nodules, men’s nodules were cancer about twice as often as women’s, 8 versus 4 in 100.²⁹ Nodules in children are more often cancer than in adults, 19 versus 12 in 100.³⁰ If you had radiation to the head or neck in childhood, tell your doctor, since it is a recognised risk factor.

A hot nodule is one that makes extra thyroid hormone and lights up brightly on a thyroid scan. Hot nodules have roughly half the odds of cancer of nodules that don’t overproduce hormone.³¹ They are not risk-free, though, with about 8 to 9 in 100 found to be cancer in one series.³²

Nodules Found on a PET Scan

PET-CT scans, often done for other cancers, sometimes show a bright spot in the thyroid. Across many studies, about 31 in 100 of these spots turned out to be cancer.³³ A large national study in the Netherlands found a lower rate, about 19 in 100, which was still about double that of comparable nodules.³⁴ If a PET scan flags your thyroid, expect your doctor to arrange a dedicated thyroid ultrasound.

A PET spot is not a cancer diagnosis. PET lights up tissue that is using a lot of sugar, and inflamed or overactive thyroid cells can do this just as cancer cells can. A spread-out glow over the whole thyroid usually points to inflammation of the thyroid, while a single focused spot raises more concern about a nodule. Most PET thyroid spots still turn out benign.

Your doctor will check the spot’s features on ultrasound and decide on a biopsy using the same size and score rules as for any other nodule. Because a PET spot is often treated as higher risk, they may be more willing to biopsy it than a similar nodule found another way.

If It Is Cancer, How Serious Is It

Many small thyroid cancers stay harmless. They are found in about 4 to 36 out of 100 people examined after death from other causes, so many people live their whole lives with a tiny thyroid cancer that never causes symptoms.³⁵ The sharp rise in thyroid cancer diagnoses since the 1990s comes mainly from ultrasound picking up these small, slow cancers.³⁶

The type of cancer usually tracks the biopsy result. Cancers found after a “malignant” biopsy are more often higher-risk than those found after an atypia result, 27 versus 4 in 100.³⁷ Certain gene changes found on extra testing, such as BRAF V600E, point to cancer more than 95 percent of the time, though they don’t always mean an aggressive tumor.³⁸³⁹

Papillary cancer is by far the most common thyroid cancer, and it usually grows slowly and responds well to treatment. When it does spread, it often goes first to lymph nodes in the neck, which is usually treatable and does not by itself mean a poor outlook. Rarer types such as medullary and anaplastic cancer are handled differently and can be more serious. Anaplastic cancer is very rare but fast-growing and needs urgent care, which is part of why the biopsy type matters.

For very small, low-risk papillary cancers, active surveillance is a recognised option: regular ultrasound checks instead of immediate surgery.⁴⁰ It suits cancers that are away from the edge of the thyroid and show no sign of spread. You and your doctor repeat ultrasounds on a schedule, and surgery is advised if the cancer grows or spreads. Practice varies, though. In one survey of doctors, only about 31 in 100 offered it first, while most recommended surgery.⁴¹

If you have a small low-risk cancer, ask whether monitoring, removing half the thyroid, or the whole gland suits you. Removing half the thyroid often leaves enough function to avoid daily hormone pills. Removing the whole gland means lifelong thyroid hormone tablets. The choice depends on tumor size, spread and your preferences.

What Happens When the Result Is Unclear

Molecular tests look for gene changes in the biopsy cells. Some are designed to rule cancer out and are good at confirming a nodule is benign, while others rule it in.⁴² A rule-out test is meant for when the answer is likely benign, and a negative result means the nodule can usually be monitored with ultrasound. A rule-in test looks for changes that point to cancer, and a positive result can help plan the type of surgery, including whether to remove the whole thyroid.

One gene panel raised the estimated chance of cancer from about 16 to 67 percent when a change was found.⁴³ But a gene test result is a probability. The nodule is not proven benign or cancerous until it is removed and examined. Some changes, such as RAS mutations, appear in benign nodules too, carrying a 57 to 87 percent risk.⁴⁴ A positive result like that may leave the question open and lead to surgery for a diagnosis. So ask whether molecular testing is available and covered before choosing surgery for an unclear result.

There are three paths. A repeat biopsy is simplest and sometimes gives a clear answer. A negative rule-out gene test may let you avoid surgery with ultrasound follow-up. Removing half the thyroid gives a definite diagnosis, but it is surgery for a nodule that is often benign. Your age, nodule size and preferences guide which makes sense.

Follow-up for benign or monitored nodules usually means repeat ultrasounds months to a few years apart. Stable size and appearance over several scans is reassuring, while new growth or changing features restart the evaluation.